![Welcome Ottawa Hospital and CHEO in Ottawa for starting recruiting for HiLo-Trial](https://static.wixstatic.com/media/8f04fc_42ed7831cd0f492b8661480e65d8451e~mv2.png/v1/fill/w_319,h_240,fp_0.50_0.50,q_95,enc_auto/8f04fc_42ed7831cd0f492b8661480e65d8451e~mv2.png)
- May 23
- 2 min
Welcome Ottawa Hospital and CHEO in Ottawa for starting recruiting for HiLo-Trial
Oxygen is a vital element in the care of preterm infants and has been given more often than any other drug over the past 80 years....
![First Canadian Patient recruited into the DOXA-Trial: Doxapram versus placebo in preterm newborns](https://static.wixstatic.com/media/8f04fc_43cb1400e2fc417380801ed5b7bff7eb~mv2.png/v1/fill/w_319,h_240,fp_0.50_0.50,q_95,enc_auto/8f04fc_43cb1400e2fc417380801ed5b7bff7eb~mv2.png)
- May 15
- 2 min
First Canadian Patient recruited into the DOXA-Trial: Doxapram versus placebo in preterm newborns
Today we can announce, that we have recruited the first canaidan Patient into the DOXA-Trial. Background: Apnoea of prematurity (AOP) is...